.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

EXEMESTANE Drug Profile

« Back to Dashboard
Exemestane is a drug marketed by Roxane and Alvogen Malta and is included in two NDAs. It is available from three suppliers.

The generic ingredient in EXEMESTANE is exemestane. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the exemestane profile page.

Summary for Tradename: EXEMESTANE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list3
Drug Prices: :see details

Pharmacology for Tradename: EXEMESTANE

Drug ClassAromatase Inhibitor
Mechanism of ActionAromatase Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roxane
EXEMESTANE
exemestane
TABLET;ORAL077431-001Apr 1, 2011RXNo► subscribe► subscribe
Alvogen Malta
EXEMESTANE
exemestane
TABLET;ORAL200898-001Jul 28, 2014RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc